MAPK3 and frontotemporal dementia: Phosphopeptides derived from EGFR, ERK1/2, and p38 MAPK were identified by phosphoproteomics analysis in LIM1215 cells treated with DMSO (ctr), FTD, panitumumab (Pmab), or a combination of FTD and panitumumab (FTD + Pmab).